We are thrilled to announce that thanks to your incredible support, we have successfully raised $62,398 for Complex Lymphatic Anomalies (CLA) research through this year’s Million Dollar Bike Ride (MDBR)! This achievement has not only met but exceeded our expectations, reaching our maximum match funding opportunity. Your generosity is paving the way for groundbreaking research and better treatments.
A Heartfelt Thank You
This accomplishment is yours as much as it is ours. Whether you joined us in person or supported from afar, your dedication has been instrumental. Participants from around the globe came together with a shared vision, demonstrating that distance is no barrier when it comes to making a difference. Your enthusiasm and commitment have been truly inspiring.
A Look at Our Journey
Since our first participation in the MDBR, LGDA has raised over one million dollars for CLA research. This incredible milestone reflects the power of our community and the collective impact of every donor, volunteer, and participant involved.
Looking Forward
With the funds raised, we are excited to announce that the grant application for these funds will open in mid-August. This will provide an opportunity for researchers and scientists to propose innovative projects that aim to understand and combat CLA more effectively.
A Continuing Commitment
Our journey does not end here. The battle against CLA continues, and with each fundraising event, we move closer to a cure. Your ongoing support and advocacy remain crucial as we forge ahead with new research initiatives and community support efforts.
Join Us Again
Stay tuned for more updates and upcoming events. Your unwavering support has been a beacon of hope for countless families affected by CLA, and we invite you to continue this journey with us. Together, we can make a lasting impact and change lives.
Once again, thank you from the bottom of our hearts. Your support not only meets goals—it transforms lives. We are immensely grateful for your spirit, generosity, and belief in our mission. Here’s to more breakthroughs and continued success in our fight against CLA!
